Charles River LaboratoriesCRLEarnings & Financial Report
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.
CRL Q4 2025 Key Financial Metrics
売上高
$994.2M
粗利益
N/A
営業利益
$-283.4M
純利益
$-276.6M
粗利益率
N/A
営業利益率
-28.5%
純利益率
-27.8%
前年比成長
-0.8%
EPS
$-5.57
資金フロー
Charles River Laboratories Q4 2025 Financial Summary
Charles River Laboratories reported revenue of $994.2M for Q4 2025, with a net profit of $-276.6M (-27.8% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $994.2M |
|---|---|
| Net Profit | $-276.6M |
| Gross Margin | N/A |
| Operating Margin | -28.5% |
| Report Period | Q4 2025 |
Charles River Laboratories Annual Revenue by Year
Charles River Laboratories annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.0B).
| Year | Annual Revenue |
|---|---|
| 2025 | $4.0B |
| 2024 | $4.0B |
| 2023 | $4.1B |
| 2022 | $4.0B |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $1.01B | $1.03B | $1.01B | $1.00B | $984.2M | $1.03B | $1.00B | $994.2M |
| 前年比成長 | N/A | -0.3% | -4.7% | N/A | -2.7% | 0.6% | -0.5% | -0.8% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $8.15B | $7.95B | $8.00B | $7.53B | $7.58B | $7.56B | $7.51B | $7.14B |
| 総負債 | $4.45B | $4.18B | $4.18B | $4.02B | $4.34B | $4.16B | $4.06B | $3.92B |
| 株主資本 | $3.64B | $3.72B | $3.78B | $3.46B | $3.19B | $3.35B | $3.41B | $3.16B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $129.9M | $193.5M | $251.8M | $159.4M | $171.7M | $204.6M | $213.8M | $147.5M |
Other Health Care Companies
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
TECH
Bio-Techne
売上高
$295.9M
純利益
$38.0M
DHR
Danaher Corporation
売上高
$6.1B
純利益
$908.0M
IQV
IQVIA
売上高
$4.4B
純利益
$514.0M
MTD
Mettler Toledo
売上高
$1.1B
純利益
$285.8M
TMO
Thermo Fisher Scientific
売上高
$11.1B
純利益
$1.6B
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B